tiprankstipranks
Advertisement
Advertisement

DRMA Stock Latest News

Dermata Therapeutics Shareholders Approve Equity Plan and Directors
Company AnnouncementsDermata Therapeutics Shareholders Approve Equity Plan and Directors
1M ago
8K
DRMA
Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4
PremiumRatings
Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4
2M ago
DRMA
Dermata receives notice of acceptance of Australian patent application
PremiumThe Fly
Dermata receives notice of acceptance of Australian patent application
3M ago
DRMA
Dermata Therapeutics price target lowered to $4 from $10 at Maxim
PremiumThe Fly
Dermata Therapeutics price target lowered to $4 from $10 at Maxim
3M ago
DRMA
Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing
PremiumThe Fly
Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing
4M ago
DRMA
Dermata Therapeutics announces release of Tome Skincare
PremiumThe FlyDermata Therapeutics announces release of Tome Skincare
4M ago
DRMA
Dermata Therapeutics Announces Board Resignation and Size Reduction
Premium
Company Announcements
Dermata Therapeutics Announces Board Resignation and Size Reduction
4M ago
8K
DRMA
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
Premium
Company Announcements
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
5M ago
8K
DRMA
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
PremiumThe Fly
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
5M ago
DRMA
Dermata Therapeutics receives notice of grant of patent for acne treatment
PremiumThe Fly
Dermata Therapeutics receives notice of grant of patent for acne treatment
6M ago
DRMA
Dermata Therapeutics Raises Capital via December Private Placement
PremiumCompany Announcements
Dermata Therapeutics Raises Capital via December Private Placement
6M ago
8K
DRMA
Dermata Therapeutics prices 2.02M shares at $2.04 in private placement
PremiumThe Fly
Dermata Therapeutics prices 2.02M shares at $2.04 in private placement
6M ago
DRMA
Dermata Therapeutics to reveal brand name for OTC skincare business
PremiumThe FlyDermata Therapeutics to reveal brand name for OTC skincare business
7M ago
DRMA
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
Premium
Ratings
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
7M ago
DRMA
Dermata Therapeutics files $100M mixed securities shelf
Premium
The Fly
Dermata Therapeutics files $100M mixed securities shelf
7M ago
DRMA
Dermata Therapeutics Ends License Agreement with Villani
PremiumCompany Announcements
Dermata Therapeutics Ends License Agreement with Villani
8M ago
8K
DRMA
Dermata Therapeutics Shifts Focus to OTC Skincare
PremiumCompany Announcements
Dermata Therapeutics Shifts Focus to OTC Skincare
8M ago
8K
DRMA
Dermata Therapeutics Increases Stock Offering by $1.79M
PremiumCompany Announcements
Dermata Therapeutics Increases Stock Offering by $1.79M
8M ago
8K
DRMA
Dermata says Australian Patent Office accepts Spongilla tech application
PremiumThe Fly
Dermata says Australian Patent Office accepts Spongilla tech application
9M ago
DRMA
Dermata Therapeutics Presents Promising Phase 3 Trial Results
PremiumCompany AnnouncementsDermata Therapeutics Presents Promising Phase 3 Trial Results
10M ago
8K
DRMA
Dermata Shifts Focus to Over-the-Counter Dermatology
Premium
Company Announcements
Dermata Shifts Focus to Over-the-Counter Dermatology
10M ago
8K
DRMA
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
Premium
The Fly
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
10M ago
DRMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >